New Study Examines Fixative Solutions Used in Skin Biopsy Test for Small Fiber Neuropathy
Cautions that one method may provide incorrect diagnosis
NEW YORK, January 20, 2016 /PRNewsire/ — Therapath LLC, a leader in neuropathology, finalized a comparison study of the most common fixation methods used in Epidermal Nerve Fiber Density (ENFD) testing for the determination of small fiber neuropathy. The study concluded that proper fixation technique is critical for test accuracy.
The study, published in Clinical Neuropathology, compared the results of immune staining on tissue shipped in PLP (2% paraformaldehyde lysine periodate) fixative and Zamboni’s (2% paraformaldehyde, picric acid) solution. The study also looked into the effects of ambient shipping on biopsy specimens shipped in Zamboni’s solution.
The published study can be found in Clinical Neuropathology Volume 35, No. 1/2016 (January/February)
The study reached two significant conclusions:
- PLP and Zamboni’s fixatives can be used interchangeably for fixation of punch skin biopsies and determination of the ENFD when the samples are kept cool during transit.
- Specimens shipped in Zamboni’s solution at ambient temperature presented with a significant reduction of immune staining that could lead to an incorrect diagnosis of small fiber neuropathy.
Therapath currently offers ENFD testing to hospitals, private practices, reference laboratories, and research organizations. Therapath offers a choice of PLP or Zamboni’s fixative and always provides protective shipping coolers and cold packs for transportation. Services are offered worldwide.
About Therapath Neuropathology:
Therapath Neuropathology is a privately held specialized laboratory with six board certified neuropathologists. The company is licensed through CLIA and accredited by the College of American Pathology (CAP).
In addition to testing for small fiber neuropathy, Therapath offers brain and spinal cord autopsy pathology, muscle and nerve biopsy pathology, and ophthalmic pathology.
Contact Information:
Geoffrey Whitehouse
Therapath Neuropathology
800.681.4338
gwhitehouse@therapath.com
Related Articles
Research Finds Nerve Damage in Patients with Fibromyalgia
Becky Tsai2022-09-05T17:50:29-05:00
Therapath, LLC reports that new findings have revealed that patients diagnosed with fibromyalgia may also have a diagnosable small fiber neuropathy. [Read More]
Quality of Life and Usefulness of Skin Biopsy in Small Fiber Neuropathy (SFN)
Becky Tsai2022-09-05T17:51:25-05:00
Bakkers et al examined a total of 265 patients diagnosed with small fiber neuropathy (SFN). They found that SFN was associated with a severe impairment in Quality of Life...[Read More]
New Upper Extremity Standard Biopsy Sites for Diagnosis of Small Fiber Neuropathy
Becky Tsai2022-09-05T17:52:41-05:00
Therapath LLC has established normative values for two upper limb body sites that can now be used to evaluate 3mm punch skin biopsy specimens...[Read More]
United Healthcare Signs Therapath Neuropathology to National Agreement to Provide Specialty Neuropathology Services to United Healthcare Members
Becky Tsai2022-09-05T17:54:35-05:00
Therapath LLC, the leader in comprehensive diagnostic and consultative neuropathology laboratory services, has signed a national contract with United Healthcare...[Read More]
New Study Examines Fixative Solutions Used in Skin Biopsy Test for Small Fiber Neuropathy
Cautions that one method may provide incorrect diagnosis
NEW YORK, January 20, 2016 /PRNewsire/ — Therapath LLC, a leader in neuropathology, finalized a comparison study of the most common fixation methods used in Epidermal Nerve Fiber Density (ENFD) testing for the determination of small fiber neuropathy. The study concluded that proper fixation technique is critical for test accuracy.
The study, published in Clinical Neuropathology, compared the results of immune staining on tissue shipped in PLP (2% paraformaldehyde lysine periodate) fixative and Zamboni’s (2% paraformaldehyde, picric acid) solution. The study also looked into the effects of ambient shipping on biopsy specimens shipped in Zamboni’s solution.
The published study can be found in Clinical Neuropathology Volume 35, No. 1/2016 (January/February)
The study reached two significant conclusions:
- PLP and Zamboni’s fixatives can be used interchangeably for fixation of punch skin biopsies and determination of the ENFD when the samples are kept cool during transit.
- Specimens shipped in Zamboni’s solution at ambient temperature presented with a significant reduction of immune staining that could lead to an incorrect diagnosis of small fiber neuropathy.
Therapath currently offers ENFD testing to hospitals, private practices, reference laboratories, and research organizations. Therapath offers a choice of PLP or Zamboni’s fixative and always provides protective shipping coolers and cold packs for transportation. Services are offered worldwide.
About Therapath Neuropathology:
Therapath Neuropathology is a privately held specialized laboratory with six board certified neuropathologists. The company is licensed through CLIA and accredited by the College of American Pathology (CAP).
In addition to testing for small fiber neuropathy, Therapath offers brain and spinal cord autopsy pathology, muscle and nerve biopsy pathology, and ophthalmic pathology.
Contact Information:
Geoffrey Whitehouse
Therapath Neuropathology
800.681.4338
gwhitehouse@therapath.com
Related Articles
Research Finds Nerve Damage in Patients with Fibromyalgia
Becky Tsai2022-09-05T17:50:29-05:00
Therapath, LLC reports that new findings have revealed that patients diagnosed with fibromyalgia may also have a diagnosable small fiber neuropathy. [Read More]
Quality of Life and Usefulness of Skin Biopsy in Small Fiber Neuropathy (SFN)
Becky Tsai2022-09-05T17:51:25-05:00
Bakkers et al examined a total of 265 patients diagnosed with small fiber neuropathy (SFN). They found that SFN was associated with a severe impairment in Quality of Life...[Read More]
New Upper Extremity Standard Biopsy Sites for Diagnosis of Small Fiber Neuropathy
Becky Tsai2022-09-05T17:52:41-05:00
Therapath LLC has established normative values for two upper limb body sites that can now be used to evaluate 3mm punch skin biopsy specimens...[Read More]
United Healthcare Signs Therapath Neuropathology to National Agreement to Provide Specialty Neuropathology Services to United Healthcare Members
Becky Tsai2022-09-05T17:54:35-05:00
Therapath LLC, the leader in comprehensive diagnostic and consultative neuropathology laboratory services, has signed a national contract with United Healthcare...[Read More]
